| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:3003.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Immunology (F.S.M., G.A.M., J.C.S.A., J.S.S.) and Pharmacology (F.L.A.C.M., F.Q.C.), School of Medicine-USP, Ribeirão Preto, SP, Brazil.
Correspondence to Dr João S. Silva, Department of Immunology, School of Medicine-USP, Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto, SP, Brazil. E-mail jsdsilva{at}fmrp.usp.br
| Abstract |
|---|
|
|
|---|
Methods and ResultsMouse cardiomyocytes were
isolated, infected with T cruzi, and evaluated for
induction of inducible NOS (iNOS), nitrite production,
trypanocidal activity, and cytokine and chemokine mRNA
expression. We found that T cruziinfected murine
embryonic cardiomyocytes produced nitrite and expressed
mRNAs for the chemokines chemokine growth-related oncogene,
monokine induced by interferon-
, macrophage inflammatory
protein-2, interferon-
inducible protein, RANTES, and monocyte
chemotactic protein, for iNOS, and for the cytokines tumor
necrosis factor (TNF)-
and interleukin (IL)-1ß. Separate addition
of IL-1ß, interferon-
, TNF-
or monocyte chemotactic protein,
macrophage inflammatory protein-2, and
interferon-
inducible protein, to cultured
cardiomyocytes resulted in NO production but low
trypanocidal activity. However, simultaneous addition of
IL-1ß, interferon-
, and TNF-
or the chemokines to cultures
resulted in the induction of iNOS, high levels of nitrite, and a marked
trypanocidal activity. The iNOS/L-arginine pathway mediated
the latter activity, inasmuch as it was inhibited by treatment with
NG-monomethyl-L-arginine.
ConclusionsThese results indicate that iNOS activation and the proinflammatory cytokines and chemokines produced by cardiomyocytes are likely to control parasite growth and cell influx, thus contributing to the pathogenesis of chagasic cardiomyopathy seen in T cruziinfected mice.
Key Words: heart diseases myocarditis myocytes interleukins nitric oxide
| Introduction |
|---|
|
|
|---|
Recently, we and others have shown that resistance to T
cruzi infection is associated with the capacity of lymphocytes to
generate interferon (IFN)-
, which in turn can activate
macrophages to produce NO, the main effector molecule that
controls intracellular T cruzi
multiplication.4 5 NO is synthesized in
macrophages by inducible NO synthase (iNOS), which is induced
by IFN-
acting synergistically with tumor necrosis factor
(TNF)-
.6 Both of these cytokines are produced
during the acute phase of T cruzi
infection7 8 9 concomitantly with an increase in the
plasma concentration of nitrite, the end product of the activation
of the L-arginine/NO pathway.5
In addition to macrophages, many other cells are able to
produce NO by use of the inducible or constitutive isoforms of the NO
synthase (NOS) enzyme. For example, murine myocardial cells produce NO
in vitro via the induction of NOS by cytokines such as IFN-
and interleukin (IL)-1ß10 or by IL-6 and TNF-
in the presence of lipopolysaccharide.11
Furthermore, iNOS has been shown to be inducible in the
myocardium of animals infected with
coxsackievirus12 or with T
cruzi13 and in mice with experimental autoimmune
myocarditis.14
The ability of NO to mediate microbicidal activity against a wide
variety of parasites,15 including T
cruzi,4 5 9 the observation that myocytes
produce NO in response to TNF-
and IL-1ß,10 11 and
the fact that these cytokines are detected in the heart of
T cruziinfected rats13 prompted us to
investigate whether cardiac myocytes could be involved in NO-dependent
trypanocidal activity. Also, because we have shown that T
cruziinfected macrophages produce chemokines that
enhance NO production and microbicidal
activity16 and because rat myocardial cells
stimulated with TNF-
and IL-1ß produce chemokines,17
we investigated whether T cruziinfected myocytes could
express chemokines and whether these mediators could stimulate cultured
cardiac myocytes to produce NO.
We showed that parasite-infected cardiomyocytes express
message for TNF-
, IL-1ß, and iNOS and for the chemokines
chemokine growth-related oncogene (KC/GRO), macrophage
inflammatory protein (MIP)-2, monokine induced by interferon-
(Mig),
interferon-
-inducible protein (Crg-2/IP-10), RANTES, and monocyte
chemotactic protein (JE/MCP-1). IFN-
, IL-1ß, and
TNF-
stimulated or chemokine-stimulated cardiomyocytes
produce critical levels of NO that control T cruzi
replication. The release of cytokines and chemokines by
infected cardiomyocytes may be essential not only for NO
production locally but also for the modulation of leukocyte
recruitment at the site of the infected tissue.
| Methods |
|---|
|
|
|---|
Embryonic Cardiomyocyte Cultures
Heart cell cultures were prepared as previously
described.18 Briefly, hearts from 19- to 20-day-old BALB/c
mouse embryos were dissected, minced, and incubated for 5 minutes at
37°C in 0.05% trypsin (GIBCO-BRL) and 0.01% collagenase
type II (Worthington Biochemical Corp) in a Ca2+-
and Mg2+-free PBS solution. Trypsin activity was
interrupted by adding 10% FBS (Hyclone). Tissue clumps were incubated
8 or 9 times in a trypsin-collagenase solution. After
trypsinization, the suspension was centrifuged, and the cell
pellet was suspended in DMEM supplemented with 15% horse serum, 5%
FBS, 2% chick embryo extract, 1 mmol/L glutamine, 1000 U/mL
penicillin, and 50 mg/mL streptomycin (all from Sigma Chemical Co). For
cardiomyocyte enrichment, the cell suspension was preplated
in tissue culture flasks and incubated at 37°C for 45 minutes in a
5% CO2 atmosphere, after which time the cultures
flasks were gently shaken, and the unattached myocytes were withdrawn
with a pipette. The cells were then plated on a gelatin-treated 24-well
tissue plate (Corning), and the medium was replaced daily. The
percentage of CD14+ and
CD11b+ cells decreased significantly after cell
preadhesion, reaching values close to zero (0.57% and 0.04%,
respectively) when the cells were preincubated in uncoated plates for
45 minutes.
Evaluation of NO2- Production
by Cardiomyocytes
Cardiomyocyte suspensions (1x106
cells/mL) were plated onto 24-well tissue culture plates and incubated
overnight until spontaneous contractility was observed.
The cardiomyocytes were then infected at a parasite-to-cell
ratio of 5:1 for 3 hours, after which the extracellular parasites were
removed, and the cells were incubated at 37°C in 5%
CO2 in the presence or absence of 100 U/mL of
recombinant murine IFN-
, IL-1ß, and TNF-
(GIBCO), 100
ng/mL of monocyte chemotactic protein (MCP)-1, MIP-2, Crg-2, and RANTES
(all from R&D Systems), and 400 µmol/L of
NG-monomethyl-L-arginine
(L-NMMA, an L-arginine analogue NOS
inhibitor). The supernatants were harvested at different
times after infection and assayed for nitrite concentration by mixing
0.1 mL of culture supernatant with 0.1 mL of Griess
reagent.19 Absorbance at 540 nm was read 10 minutes
later, and NO2- concentration
was determined by reference to a standard curve of 1 to 200
µmol/L NaNO2.
Determination of NOS Activity: Effect of Different NOS
Inhibitors and EGTA
NOS activity of infected cardiomyocytes was
evaluated 72 hours after incubation with DMEM or stimulation with
IFN-
, TNF-
, and IL-1ß (100 U/mL) in the presence or absence of
N
-iminoethyl-L-ornithine
(L-NIO), L-NMMA, and aminoguanidine (200 to 800 µmol/L) by use
of a modification of the citrulline assay.20 Briefly,
at the indicated times, the cell culture supernatants were replaced
with 500 µL of L-argininefree DMEM supplemented with
L-valine (60 mmol/L), 50 µmol/L cold
L-arginine, and 1 µCi/mL
[14C]arginine. After 4 hours of incubation, 400
µL of the supernatant was added to 100 µL of Dowex AG-50X8, basic
sodium form (ratio of water to resin 1:1). The tubes were
centrifuged, and 400 µL of the supernatant containing labeled
L-citrulline was added to a vial containing scintillation
solution. The L-citrulline production was expressed
as counts per minute per 106 cells per hour. The
activity of Ca2+-dependent and -independent
enzyme was determined in cardiomyocytes cultured with
cytokines and parasites by the classic citrulline
assay.21
Cardiomyocyte and Macrophage Cultures for RNA
Extraction
BALB/c mouse inflammatory macrophages were harvested
from peritoneal cavities 3 days after injection of 1 mL of 3% sodium
thioglycollate. The cells were washed and suspended to
1x106 cells/mL in RPMI-1640 (Sigma),
supplemented with 5% FBS,
5x10-5 mol/L
2-mercaptoethanol, 2 mmol/L L-glutamine, and
antibiotics. The adherent cells were obtained after 2 to 4 hours of
incubation of single-cell suspensions in 24-well tissue culture plates
at 37°C. Nonadherent cells were removed, and trypomastigote forms
were added at a 5:1 parasite-to-cell ratio to macrophages or
cardiomyocytes and incubated for 12 hours at 37°C in a
humidified chamber containing 5% CO2. The cells
were then washed 3 times, and 0.5 mL of Trizol LS reagent was added to
each well, followed by incubation at room temperature for 5 minutes and
storage at -70°C until RNA extraction.
Chemokine and Cytokine mRNA Detection
Total RNA was extracted by use of the Trizol LS reagent. Copy
DNA was synthesized by use of Superscript II reverse transcriptase
(GIBCO). Expression of mRNA was analyzed by reverse
transcriptasePCR for the following: chemokine growth-related
oncogene (KC/GRO), MIP-2, MIP-1
, MIP-1ß, monokine induced by
IFN-
(Mig), interferon-induced protein (Crg-2/IP10), RANTES, and
JE/MCP-1; cytokines TNF-
, IL-1ß, and IFN-
; iNOS; and
ß-actin. PCRs were performed by use of Taq polymerase (GIBCO) in a
PTC-100 thermal cycler (MJ Research). Reaction conditions were 35
cycles of 1 minute at 94°C, 1 minute at 54°C, and 2 minutes at
72°C, with a final extension step of 7 minutes at 72°C. For each
set of primers, a negative sample (water) was run in parallel. PCR
products were separated by acrylamide gel
electrophoresis and stained with silver nitrate. The PCR method for the
chemokines tested has been validated in the laboratory by using
plasmids containing the gene for each chemokine (kindly provided by J.
Farber, National Institute of Allergy and Infectious Disease,
National Institutes of Health, Bethesda, Md). The CXC and CC
chemokines, cytokines, and ß-actin sequences used have been
previously described.22 23
Cardiomyocyte Microbicidal Activity
To evaluate parasite growth, cardiac cell suspensions
presenting spontaneous contractility were infected,
the extracellular parasites were removed, and the cells were incubated
with or without cytokines, chemokines, or L-NMMA as described
above. Parasite growth was evaluated by daily counting of the
trypomastigote forms released on days 3 to 6 after infection. The
intracellular amastigote growth rate was evaluated in
cardiomyocytes plated (5x105
cell/mL) onto chamber slides (Nunc Inc), as
described.9
Statistical Analysis
The results are expressed as mean±SEM of the triplicate
cultures or experiments. Statistical analysis was performed by
ANOVA followed by the Student-Newman-Keuls test (INSTAT software,
GraphPad). A value of P<0.05 was considered to indicate
significance.
| Results |
|---|
|
|
|---|
, IL-1ß, and
iNOS mRNA in Cardiomyocytes
, IL-1ß, IFN-
, and iNOS mRNA was
detected in hearts obtained from mice on day 9 after infection with
T cruzi but not in hearts from uninfected control mice
(Figure 1A
, IL-1ß, and iNOS but not for
IFN-
(Figure 1B
|
NO2- Production by Infected
Cardiomyocytes
Significant levels of nitrite were detected in supernatants of
cardiomyocytes incubated for 120 hours with IFN-
,
IL-1ß, and/or TNF-
and infected with T cruzi. Nitrite
was not detected in the supernatants of control cultures (Figure 2
). Simultaneous addition of
these 3 cytokines to the cells resulted in an even higher
amount of NO2-
production. Addition of L-NMMA resulted in a drastic decrease
in the levels of nitrite detected in the supernatants (Figure 2
). We next observed that the cytokine mixture enhanced
NOS activity, which was inhibited in a dose-dependent manner by L-NMMA,
L-NIO, and aminoguanidine. Uninfected cardiomyocytes had no
detectable NOS activity (Figure 3A
).
|
|
Next, we evaluated Ca2+-independent (iNOS) and
Ca2+-dependent (constitutive NOS [cNOS])
activity in cardiomyocyte lysates previously infected and
cultured in the presence of cytokines. We found that most
[14C]L-arginine that converted to
[14C]L-citrulline after a 24- or
48-hour culture was due to iNOS (
87%), inasmuch as it was not
inhibited by EGTA (Figure 3B
), which blocks cNOS activity. We
concluded that iNOS was the major isoform of NOS present in
infected murine cardiomyocytes stimulated with IFN-
,
TNF-
, and IL-1ß. A significant expression of iNOS enzyme was
detected by immunohistochemistry in cells infected with T
cruzi but not in control myocytes (data not shown).
Microbicidal Activity of Cytokine-Stimulated
Cardiomyocytes
To address the question of whether NO produced by
cytokine-stimulated cardiomyocytes could control
parasite replication, established cultures were infected and cultured
with IFN-
, TNF-
, and/or IL-1ß, and the growth of parasites was
determined. As shown in Figure 4
, all
cytokines significantly inhibited parasite growth. The addition
of IFN-
or of all cytokines simultaneously
resulted in a further reduction of the numbers of parasites released
(Figure 4A
). The inhibition of parasite growth was significantly
blocked by the addition of L-NMMA to the cultures, suggesting that NO
production was critical for the microbicidal activity of
cytokine-stimulated myocytes. These results were confirmed by
determining the number of intracellular amastigotes in infected
cardiomyocytes (Figure 4B
).
|
Trypomastigote-Induced Chemokine mRNA Expression in Infected
Cardiac Myocytes
We next investigated whether T cruziinfected
cardiomyocytes and macrophages expressed chemokine
mRNA. A message for RANTES but not for other chemokines was detected in
cardiomyocytes incubated with medium only. Control
uninfected macrophages expressed mRNA for RANTES and Mig.
However, after T cruzi infection, the
cardiomyocytes expressed messages for JE, RANTES, KC,
MIP-2, Mig, and Crg-2 chemokines. For comparison, positive messages for
JE, RANTES, MIP-1
, MIP-1ß, KC, MIP-2, Mig, and Crg-2 were found in
T cruziinfected macrophages (Figure 5
). The message for lymphotactin,
T-cell activation gene, lipopolysaccharide-induced CXC chemokine,
stromal cell-derived factor 1
, stromal cell-derived factor 1ß, and
osteopontin was not detected in control or infected
cardiomyocytes and macrophages (data not
shown).
|
NO2- Production and Microbicidal
Activity of Chemokine-Stimulated Cardiomyocytes
We also examined whether the chemokines could be involved in the
regulation of NO production and microbicidal activity by
infected cardiomyocytes. The addition of parasites with or
without RANTES (Figure 6A
) or MIG,
MIP-1ß, and KC (data not shown) resulted in small amounts of nitrite
production. The addition of JE, MIP-2, or Crg-2 together with
parasites led to significant nitrite production (Figure 6A
) that was
2 times higher than that obtained in the absence
of parasites (data not shown). Simultaneous addition of JE,
RANTES, MIP-2, and Crg-2 led to significant NO synthesis (Figure 6A
), which was significantly inhibited by L-NMMA (Figure 6C
). The levels of NO synthesized by infected
cardiomyocytes after the addition of exogenous JE, MIP-2,
and Crg-2 or of all chemokines simultaneously were
sufficient to control parasite multiplication (Figure 6B
). In
agreement with the levels of NO produced, JE and MIP-2 were more
effective in controlling parasite growth than were RANTES and Crg-2
(Figure 6B
). Again, the addition of L-NMMA to
cardiomyocytes cultured with the chemokine mixture or with
JE resulted in significant inhibition of parasite killing (Figure 6D
).
|
| Discussion |
|---|
|
|
|---|
We first showed that heart tissue collected from T
cruziinfected mice expresses mRNA to IFN-
, TNF-
, IL-1ß,
and iNOS. Hearts from rats infected with T cruzi also
express iNOS and proinflammatory cytokines.13
Because the expression of cytokines and iNOS has been evaluated
only in whole cardiac tissue, we investigated whether
cardiomyocytes could be one of the cellular sources of
cytokine mRNA expression. We detected mRNA expression for the
cytokines TNF-
and IL-1ß and for iNOS in
cardiomyocytes cultured with trypomastigote forms. These
results show that cardiomyocytes are potential cellular
sources of cytokines and iNOS in vivo.
iNOS protein induction in cardiomyocytes was confirmed by its ability to convert [14C]L-arginine to [14C]L-citrulline in an EGTA-independent manner and is supported by the fact that 2 known selective iNOS inhibitors (L-NIO and aminoguanidine) significantly blocked this conversion. Not only were the iNOS message and activity upregulated, but there was also significant NO2- production after infection of cultured myocytes. These results demonstrate that parasites induce NO production in cardiomyocytes via upregulation of the expression of the inducible isoform of NOS.
The mechanisms by which iNOS expression is induced by T
cruzi in cardiac myocytes remain to be determined. One possibility
is that parasite-secreted products, such as trypomastigones
glycosylphosphatidylinositolanchored mucin-like
glycoproteins24 and lipopolysaccharide-like
molecules,25 may induce the enzyme directly.
Alternatively, iNOS expression may result from autocrine stimulation by
cytokines and chemokines released by cardiomyocytes
after T cruzi infection. In this regard, T cruzi
induces the production of ß-chemokines by
macrophages16 and the expression of mRNA for
JE, RANTES, KC, MIP-2, Mig, and Crg-2 by cardiomyocytes
(Figure 5
). The parasites also induce TNF-
and IL-12
synthesis by macrophages, which results in IFN-
production by T and NK cells.9 26 The presence of
IFN-
and chemokines in heart tissue of infected mice, in association
with IL-1 and TNF-
, could lead to the induction of iNOS. The TNF-
produced may also trigger chemokine production, as previously
described.27
Inasmuch as there was considerable induction of iNOS on stimulation of infected cardiomyocytes with cytokines, we investigated whether iNOS-derived NO could mediate trypanocidal activity. Incubation of cardiomyocytes with cytokines or chemokines resulted not only in NO synthesis but also in significant trypanocidal activity. We also found that the addition of selective iNOS inhibitors significantly inhibited NO production and parasite killing, convincingly demonstrating that cardiomyocyte-derived NO possesses significant trypanocidal activity. The partial inhibition of parasite killing observed in infected cells cultured with cytokines or chemokines in the presence of L-NMMA could occur because the dose of NOS inhibitor used (400 µmol/L) was unable to completely abrogate the NO production.
The importance of the production of these chemotactic
cytokines by cardiomyocytes in disease outcome and
host immunopathology during T cruzi infection is not known,
but these cells may play an important role in driving or maintaining
the local inflammatory response. It is possible that the early
chemokine-and cytokine-mediated cardiomyocyte
activation may play an essential role in the containment of parasite
dissemination during the acute phase of infection. On the other hand,
the release of parasites from the amastigote nests within cardiac
tissue may act locally to enhance the control of parasite replication
and spread in the host tissues. Nevertheless, the induction of these
molecules in cardiomyocytes could also play a detrimental
role in chronic Chagas heart disease.1 28 Nitric
oxide may directly regulate the contractile properties of muscle
cells10 and lead to depressed cardiac
function29 and myocardial damage.30 This
could further potentiate chemokine-driven inflammation and tissue
damage. Moreover, TNF-
may be an autocrine contributor to the
myocardial dysfunction seen in patients with chagasic
cardiomyopathy.28 We believe that
elucidation of the role of chemokines and cytokines in the
mediation of inflammatory responses in patients with chagasic
cardiomyopathy may have important implications for
the development of a therapy designed to protect the host against the
infection and the pathology induced by T cruzi
infections.
| Acknowledgments |
|---|
Received May 23, 2000; revision received June 30, 2000; accepted July 5, 2000.
| References |
|---|
|
|
|---|
treated
macrophages against Trypanosoma cruzi involves an
L-arginine-dependent, nitrogen oxide-mediated mechanism inhabitable by
interleukin-10 and transforming growth factor-ß. Eur J
Immunol. 1992;22:25012506.[Medline]
[Order article via Infotrieve]
for chemokine expression in models of
acute lung inflammation. Immunology. 1998;95:512521.[Medline]
[Order article via Infotrieve]
-primed macrophages.
J Immunol.. 1997;159:61316139.[Abstract]This article has been cited by other articles:
![]() |
D. G.J. Batista, C. F. Silva, R. A. Mota, L. C. Costa, M. N.L. Meirelles, M. Meuser-Batista, and M. N.C. Soeiro Trypanosoma cruzi Modulates the Expression of Rabs and Alters the Endocytosis in Mouse Cardiomyocytes In Vitro J. Histochem. Cytochem., June 1, 2006; 54(6): 605 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. S. Gomes, L. M. G. Bahia-Oliveira, M. O. C. Rocha, S. C. U. Busek, M. M. Teixeira, J. S. Silva, and R. Correa-Oliveira Type 1 Chemokine Receptor Expression in Chagas' Disease Correlates with Morbidity in Cardiac Patients Infect. Immun., December 1, 2005; 73(12): 7960 - 7966. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Petersen, K. A. Krumholz, and B. A. Burleigh Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi Infect. Immun., October 1, 2005; 73(10): 6974 - 6980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Ochiel, G. A. Awandare, C. C. Keller, J. B. Hittner, P. G. Kremsner, J. B. Weinberg, and D. J. Perkins Differential Regulation of {beta}-Chemokines in Children with Plasmodium falciparum Malaria Infect. Immun., July 1, 2005; 73(7): 4190 - 4197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. M.P. Marino, A. da Silva, P. dos Santos, L. M. d. O. Pinto, R. T. Gazzinelli, M. M. Teixeira, and J. Lannes-Vieira Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES) Antagonist (Met-RANTES) Controls the Early Phase of Trypanosoma cruzi-Elicited Myocarditis Circulation, September 14, 2004; 110(11): 1443 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Trujillo, H. Budde, M. D. Pineyro, M. Stehr, C. Robello, L. Flohe, and R. Radi Trypanosoma brucei and Trypanosoma cruzi Tryparedoxin Peroxidases Catalytically Detoxify Peroxynitrite via Oxidation of Fast Reacting Thiols J. Biol. Chem., August 13, 2004; 279(33): 34175 - 34182. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Michailowsky, M. R. N. Celes, A. P. Marino, A. A. Silva, L. Q. Vieira, M. A. Rossi, R. T. Gazzinelli, J. Lannes-Vieira, and J. S. Silva Intercellular Adhesion Molecule 1 Deficiency Leads to Impaired Recruitment of T Lymphocytes and Enhanced Host Susceptibility to Infection with Trypanosoma cruzi J. Immunol., July 1, 2004; 173(1): 463 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M.E. Arantes, H. H.F. Marche, M. T. Bahia, F. Q. Cunha, M. A. Rossi, and J. S. Silva Interferon-{gamma}-Induced Nitric Oxide Causes Intrinsic Intestinal Denervation in Trypanosoma cruzi-Infected Mice Am. J. Pathol., April 1, 2004; 164(4): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Aoki, N. L. Guinazu, A. V. Pellegrini, T. Gotoh, D. T. Masih, and S. Gea Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes Am J Physiol Cell Physiol, February 1, 2004; 286(2): C206 - C212. [Abstract] [Full Text] |
||||
![]() |
L. E. Fichera, M. C. Albareda, S. A. Laucella, and M. Postan Intracellular Growth of Trypanosoma cruzi in Cardiac Myocytes Is Inhibited by Cytokine-Induced Nitric Oxide Release Infect. Immun., January 1, 2004; 72(1): 359 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Petersen and B. A. Burleigh Role for Interleukin-1{beta} in Trypanosoma cruzi-Induced Cardiomyocyte Hypertrophy Infect. Immun., August 1, 2003; 71(8): 4441 - 4447. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. P. Ferreira, E. F. Abrantes, C. V. Rodrigues, B. Caetano, G. C. Cerqueira, A. C. Salim, L. F. L. Reis, and R. T. Gazzinelli Identification and characterization of a novel mouse gene encoding a Ras-associated guanine nucleotide exchange factor: expression in macrophages and myocarditis elicited by Trypanosoma cruzi parasites J. Leukoc. Biol., December 1, 2002; 72(6): 1215 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Talvani, F. S. Machado, G. C. Santana, A. Klein, L. Barcelos, J. S. Silva, and M. M. Teixeira Leukotriene B4 Induces Nitric Oxide Synthesis in Trypanosoma cruzi-Infected Murine Macrophages and Mediates Resistance to Infection Infect. Immun., August 1, 2002; 70(8): 4247 - 4253. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. de Avalos, I. J. Blader, M. Fisher, J. C. Boothroyd, and B. A. Burleigh Immediate/Early Response to Trypanosoma cruzi Infection Involves Minimal Modulation of Host Cell Transcription J. Biol. Chem., January 4, 2002; 277(1): 639 - 644. [Abstract] [Full Text] |
||||
![]() |
I. C. Almeida and R. T. Gazzinelli Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses J. Leukoc. Biol., October 1, 2001; 70(4): 467 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. S. Aliberti, J. T. Souto, A. P. M. P. Marino, J. Lannes-Vieira, M. M. Teixeira, J. Farber, R. T. Gazzinelli, and J. S. Silva Modulation of Chemokine Production and Inflammatory Responses in Interferon-{{gamma}}- and Tumor Necrosis Factor-R1-Deficient Mice during Trypanosoma cruzi Infection Am. J. Pathol., April 1, 2001; 158(4): 1433 - 1440. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||